These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17902244)

  • 1. Aluvia tablet approved in 19 African countries.
    AIDS Patient Care STDS; 2007 Aug; 21(8):604-5. PubMed ID: 17902244
    [No Abstract]   [Full Text] [Related]  

  • 2. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving access to second-line antiretrovirals.
    The Lancet
    Lancet; 2007 Apr; 369(9570):1320. PubMed ID: 17448798
    [No Abstract]   [Full Text] [Related]  

  • 4. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
    Prescrire Int; 2007 Aug; 16(90):148. PubMed ID: 17724839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbott expands low cost Kaletra.
    AIDS Patient Care STDS; 2006 Oct; 20(10):731-2. PubMed ID: 17083155
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral approved for use in infants.
    Am Fam Physician; 2001 Jun; 63(12):2469. PubMed ID: 11430459
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaletra lower-strength pediatric tablet approved in Europe.
    AIDS Patient Care STDS; 2008 May; 22(5):437-8. PubMed ID: 18521973
    [No Abstract]   [Full Text] [Related]  

  • 9. Civil society strategy for the compulsory licensing of lopinavir/ritonavir: the Brazilian case.
    Vieira MF; Reis R; Chaves G
    HIV AIDS Policy Law Rev; 2008 Dec; 13(2-3):80-1. PubMed ID: 19297771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norvir hangover.
    Clifton CE
    Posit Aware; 2004; 15(2):7-9. PubMed ID: 15106524
    [No Abstract]   [Full Text] [Related]  

  • 11. Two more HIV protease inhibitors approved.
    Fox JL
    Nat Biotechnol; 1996 Apr; 14(4):427. PubMed ID: 9669874
    [No Abstract]   [Full Text] [Related]  

  • 12. Ugandan children receive lower-strength Aluvia.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86-7. PubMed ID: 18453040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacoeconomic aspects of lopinavir/ritonavir monotherapy].
    Escobar Rodríguez I; Esteban Alba C
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 16():47-51. PubMed ID: 19572445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaletra (ABT-378/r) approved.
    James JS
    AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbott agrees to expand access to Kaletra/Aluvia.
    AIDS Patient Care STDS; 2007 May; 21(5):366. PubMed ID: 17518529
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HIV agents. Using only lopinavir/ritonavir (Kaletra).
    TreatmentUpdate; 2008 Jan; 20(1):1-2. PubMed ID: 18320690
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL
    Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination drug approved to treat HIV.
    FDA Consum; 2001; 35(1):5. PubMed ID: 11930926
    [No Abstract]   [Full Text] [Related]  

  • 19. Abbott Laboratories increases Norvir price fivefold.
    James JS
    AIDS Treat News; 2003 Dec; (397):3-5. PubMed ID: 14989182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state of access to Kaletra.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):4-5. PubMed ID: 17228448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.